Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (859)	1/1/1998 7:19:00 PM
From: Cisco	Read Replies (2) \| Respond to of 1894

Frank, I just looked into my Crystal Ball for 1998 and here is what I see barring any mergers or acquistions. Cisco's Projected ESP for AccuMed: 4th Quarter 1997: (0.10) per share. 1st Quarter 1998: (0.06) per share. 2nd Quarter 1998: (0.02) per share. 3rd Quarter 1998: 0.00 per share. 4th Quarter 1998: 0.04 per share. Cisco's Projected Sales Revenue for AccuMed: Year ending 12/31/97: $21,000,000 Year ending 12/31/98: $35,000,000 Share price 12/31/98 based upon 3.5 X Sales = $5.50 I would put the odds of a merger or strategic alliance with another key player in this field during 1998 at 40% in which case my estimated share price may be low. Anyone else want to throw their hat into the ring? Cisco